Sunday, December 07, 2025 | 03:09 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India won't buy Pfizer, Moderna vaccines amid jump in local output: Report

The Indian government has also declined to meet the US companies' requests for legal protection over any side-effects from the use of their shots: Report

Pfizer
premium

Both vaccines cost several times more than India's main shot, Covishield, a licensed version of the AstraZeneca drug

Reuters
India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped.

That essentially means the globally popular vaccines, which their makers have pledged not to sell to private parties during the pandemic, will not be available for now in the world's two most populous countries - China and India.

The Indian government has also declined to meet the U.S. companies' requests for legal protection over any side-effects from the use of their shots, which are currently made only in the United States or

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)